FOXM1 and neoplasm: Working from knowledge that the tumor suppressor p14/p19ARF binds and inhibits FOXM1 protein, the late Costa and his colleagues developed a cell penetrating peptide, ARFWT, that mimics ARF-dependent inactivation of FOXM1 [43].